Muthusamy Shanmugam - 28 Aug 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF R&D, COO-NOVITIUM OPS, Director
Signature
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
28 Aug 2023
Transactions value $
-$3,160,750
Form type
4
Filing time
30 Aug 2023, 16:29:01 UTC
Previous filing
16 Aug 2023
Next filing
19 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$1.58M -25K -2.11% $63.06 1.16M 28 Aug 2023 Held by Esjay LLC F1, F2
transaction ANIP Common Stock Sale -$1.58M -25K -2.16% $63.37 1.13M 29 Aug 2023 Held by Esjay LLC F2, F3
holding ANIP Common Stock 47.4K 28 Aug 2023 Direct
holding ANIP Common Stock 5K 28 Aug 2023 Held by SS Pharma LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of sales on August 28, 2023. The shares were sold in multiple transactions at prices ranging from $62.57 to $64.64, inclusive.
F2 The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
F3 Reflects the weighted average price of sales on August 29, 2023. The shares were sold in multiple transactions at prices ranging from $62.4877 to $63.92, inclusive.
F4 The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.